Premium Information is available for this item - Upgrade for $1 a day

6505-01-143-4412

Usp Cephalexin Capsules

6505011434412 011434412 KEFLEX PULVULES

6505-01-143-4412 CEPHALEXIN CAPSULES,USP 6505011434412 011434412

Managed by United States
NSN Created on 3 Dec 1982
Data Last Changed
November 2023
NATO Update Count
6
NATO Data Quality
6505-01-143-4412 CEPHALEXIN CAPSULES,USP 6505011434412 011434412 1/1
NSN 6505-01-143-4412 (Generic Image) 1/1

6505-01-143-4412 Stock and Availability Marketplace 6505-01-143-4412

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
6505-01-143-4412 RQST NE eBay
eBay Updated Every Day
6505-01-143-4412 RQST eBay
Amazon Updated Every Day
6505-01-143-4412 RQST NE Amazon

6505-01-143-4412 Related Documents Related Documents 6505-01-143-4412 5+ Documents (More...)

day Upgrade your Account Upgrade 6505-00-183-8543Usp Cephalexin Capsules6505001838543 001838543 KEFLEX PULVULES
1991 AMC 0 AMSC 0 Approved Sources 6505-00-183 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-143-4412
Usp Cephalexin Capsules 6505011434412 day Upgrade your Account Upgrade 6505-01-143-4412Usp Cephalexin
KEFLEX Usp Cephalexin Capsules 6505218900807 165-6545 6505-01-143-4412 6505-21-890-0807 6505-19-000-
8467 Cephalexin Capsules 6505001711213 9179 6505-01-571-6679 6505-00-197-9200 165-6545 6505-01-143-4412
6505-21-890-0807 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-143-4412 Usp Cephalexin Capsules
6505-00-171-1213 6505-21-891-2130 6505-19-000-0208 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-143-4412
Usp Cephalexin Capsules 6505011434412 a day Upgrade your Account Upgrade 6505-01-143-4412Usp Cephalexin
Capsules6505011434412 011434412 KEFLEX PULVULES 001-0598 6505-01-259-3891 6505-00-171-1213 6505-21-891
day Upgrade your Account Upgrade 6505-01-143-4413Usp Cephalexin Capsules6505011434413 011434413 KEFLEX PULVULES
day Upgrade your Account Upgrade 6505-00-183-8543Usp Cephalexin Capsules6505001838543 001838543 KEFLEX PULVULES
day Upgrade your Account Upgrade 6505-01-143-4412Usp Cephalexin Capsules6505011434412 011434412 KEFLEX
6505001656545 001-0598 6505-01-259-3891 6505-00-171-1213 4412Usp Cephalexin Capsules6505011434412 011434412
KEFLEX PULVULES 001-0598 6505-01-259-3891 6505-00-171-1213 https//www.nsnlookup.com /fsg-65/fsc-6505
6505-21-890-0807 fsc-6505/us 6505 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-143-4412

6505-01-143-4412 Demil Restrictions 6505-01-143-4412

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: P | PMIC: U | EDC: | ADPEC:

6505-01-143-4412 is a Usp Cephalexin Capsules that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.

6505-01-143-4412 End Users End Users 6505-01-143-4412

NASA (G57V)
Effective Date:
1 Apr 1991

6505-01-143-4412 Manufacturers Approved Sources 6505-01-143-4412

6505-01-143-4412 Technical Data Datasheet 6505-01-143-4412

Characteristic
Specifications
Capsule Type [AKJC]
Any Acceptable
Capsule Content Form [CQLS]
Any Acceptable
Active Medicament Medicinal Strength [AKJA]
250.000 Milligrams Cephalexin Active Ingredient
Primary Container Type [CQCT]
Bottle
Capsule Primary Container Content Quantity [CYLZ]
40.000

6505-01-143-4412 Related Items NATO Stock Numbers Related to 6505-01-143-4412

6505-01-143-4412 Freight Data Freight Information 6505-01-143-4412

6505-01-143-4412 has freight characteristics.. 6505-01-143-4412 has a variance between NMFC and UFC when transported by rail and the description should be consulted.